News

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

  • ATLANTA , July 25, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2024 financial results will be released on Thursday, August 8, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m.
    07/25/2024

3 Earnings All-Stars With More Room to Run

  • Earnings are essential to determining which stocks will outperform. Unsurprisingly, earnings outperformers also see strong price appreciation.
    07/03/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Artivion, Inc. (AORT) can sell. Click on Rating Page for detail.

The price of Artivion, Inc. (AORT) is 27.48 and it was updated on 2024-07-27 07:01:02.

Currently Artivion, Inc. (AORT) is in undervalued.

News
    
News

Artivion Amends Agreements with Endospan

  • Provides Endospan with $25 million of Additional Debt Funding to Obtain FDA Approval for NEXUS Upfront Payment Associated with Purchase Option Reduced to $135 million, inclusive of loan off-set, and $100 million earnout minimum eliminated  ATLANTA , July 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced it has amended its credit facility and option purchase agreements with Endospan Ltd. ("Endospan"), an Israeli-based, privately-held developer of the NEXUS® Stent Graft System ("NEXUS").
    Mon, Jul. 01, 2024

Data-Driven Growth Fuels More Upside For Overlooked Artivion

  • Artivion, Inc. has continued to log double-digit revenue growth with contributions from diverse assets including its stent grafts, heart valves, and cryopreserved tissue grafts. Positive post-approval trial data for the On-X aortic valve and a successful PERSEVERE IDE study for AMDS hybrid prosthesis can drive additional revenue growth. A strong pipeline, including NEXUS and ARCEVO stent graft systems, can support a longer runway of continued revenue growth.
    Fri, Jun. 21, 2024

Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?

  • Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
    Wed, May. 08, 2024

Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript

  • Artivion, Inc. (NYSE:AORT ) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Eileen Martin - Investor Relations Pat Mackin - Chief Executive Officer Lance Berry - Chief Financial Officer Conference Call Participants Mike Matson - Needham & Company Suraj Kalia - Oppenheimer & Company Frank Takkinen - Lake Street Capital Markets Jeffrey Cohen - Ladenburg Thalmann Operator Greetings. Welcome to Artivion First Quarter 2024 Financial Conference Call.
    Mon, May. 06, 2024

Artivion (AORT) Tops Q1 Earnings and Revenue Estimates

  • Artivion (AORT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago.
    Mon, May. 06, 2024
SEC Filings
SEC Filings

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/03/2024

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/30/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/13/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/10/2024

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 04/01/2024

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/01/2024

Artivion, Inc. (AORT) - ARS

  • SEC Filings
  • 04/01/2024

Artivion, Inc. (AORT) - PRE 14A

  • SEC Filings
  • 03/21/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/21/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/18/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/15/2024

Artivion, Inc. (AORT) - 4/A

  • SEC Filings
  • 03/14/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/14/2024

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 03/11/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/07/2024

Artivion, Inc. (AORT) - S-3ASR

  • SEC Filings
  • 03/01/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/29/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/28/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/26/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/22/2024

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/14/2024

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/13/2024

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/12/2024

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/08/2024

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 01/30/2024

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/22/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 01/04/2024

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/19/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/08/2023

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 12/08/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/29/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/10/2023

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 06/30/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/12/2023

Artivion, Inc. (AORT) - S-8

  • SEC Filings
  • 06/09/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/08/2023

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 06/08/2023

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/30/2023

Artivion, Inc. (AORT) - ARS

  • SEC Filings
  • 04/05/2023

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 04/03/2023

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/03/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/03/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/01/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/21/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/16/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/15/2023

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/14/2023

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/10/2023

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/09/2023

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/08/2023

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/06/2023

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 01/27/2023

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 01/20/2023

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/16/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/10/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/07/2022

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 10/07/2022

Artivion, Inc. (AORT) - SC 13D

  • SEC Filings
  • 09/26/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/18/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/10/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/03/2022

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/26/2022

Artivion, Inc. (AORT) - S-8

  • SEC Filings
  • 05/24/2022

Artivion, Inc. (AORT) - S-8

  • SEC Filings
  • 05/23/2022

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 04/04/2022

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/04/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/09/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/07/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/01/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/24/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/22/2022

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/14/2022

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/11/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/11/2022

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/10/2022

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 02/10/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/10/2022

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/09/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/08/2022

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/27/2022

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/25/2022

Artivion, Inc. (AORT) - 8-A12B/A

  • SEC Filings
  • 01/06/2022

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/10/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/01/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/30/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/05/2021

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 10/07/2021

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 10/07/2021

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 10/07/2021

Artivion, Inc. (AORT) - PRE 14A

  • SEC Filings
  • 09/24/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/01/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/31/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/26/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/24/2021

Artivion, Inc. (AORT) - S-3ASR

  • SEC Filings
  • 08/11/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/02/2021

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/28/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/27/2021

Artivion, Inc. (AORT) - 3/A

  • SEC Filings
  • 05/19/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/10/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/07/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/04/2021

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 03/30/2021

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 03/30/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/18/2021

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 03/18/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/15/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/11/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/10/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/02/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/25/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/19/2021

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/12/2021

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/11/2021

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/10/2021

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 01/25/2021

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 01/11/2021

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/16/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/15/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/14/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/03/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/02/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/04/2020

Artivion, Inc. (AORT) - 4/A

  • SEC Filings
  • 10/01/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/17/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/16/2020

Artivion, Inc. (AORT) - D

  • SEC Filings
  • 09/14/2020

Artivion, Inc. (AORT) - S-8

  • SEC Filings
  • 08/11/2020

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 07/01/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/02/2020

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 06/01/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/29/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/27/2020

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 05/14/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/07/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/06/2020

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 03/31/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/16/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/09/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/25/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/21/2020

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/14/2020

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/12/2020

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/04/2020

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 01/29/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 01/23/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 01/21/2020

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/13/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/27/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/19/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/13/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/07/2019

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 08/08/2019

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 08/05/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/06/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/03/2019

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/31/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/29/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/24/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/17/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/14/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/07/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/03/2019

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 03/26/2019

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 03/26/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/18/2019

Artivion, Inc. (AORT) - PRE 14A

  • SEC Filings
  • 03/15/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/08/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/07/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/04/2019

Artivion, Inc. (AORT) - S-8

  • SEC Filings
  • 02/26/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/25/2019

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/21/2019

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 02/19/2019

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/15/2019

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/14/2019

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/14/2019

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/12/2019

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/08/2019

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/24/2019

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 12/11/2018

Artivion, Inc. (AORT) - S-3ASR

  • SEC Filings
  • 09/21/2018

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 09/21/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/20/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/12/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/06/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/04/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/29/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/21/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/16/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/15/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/13/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/09/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/30/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/25/2018

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 07/13/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/10/2018

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 06/27/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/15/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/05/2018

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 06/05/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/01/2018

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/31/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/25/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/18/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/15/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/11/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/10/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/08/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 04/18/2018

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/03/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 04/03/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/26/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/14/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/09/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/07/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/21/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/15/2018

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/14/2018

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/14/2018

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/12/2018

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/09/2018

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 01/25/2018

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/23/2018

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 01/05/2018

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/19/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/17/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/13/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/08/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 10/04/2017

Artivion, Inc. (AORT) - 4/A

  • SEC Filings
  • 09/06/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/06/2017

Artivion, Inc. (AORT) - 5

  • SEC Filings
  • 07/11/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/06/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/29/2017

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/26/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/24/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/18/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 04/10/2017

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 03/29/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/28/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/24/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/22/2017

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/13/2017

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/13/2017

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/09/2017

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/30/2017

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/09/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 01/05/2017

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/28/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/16/2016

Artivion, Inc. (AORT) - S-3

  • SEC Filings
  • 11/14/2016

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 11/08/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/01/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/22/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/16/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/15/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/14/2016

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 09/14/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/13/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/28/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/26/2016

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 06/21/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/03/2016

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/31/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/25/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/12/2016

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/21/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 04/19/2016

Artivion, Inc. (AORT) - 424B3

  • SEC Filings
  • 03/29/2016

Artivion, Inc. (AORT) - CORRESP

  • SEC Filings
  • 03/25/2016

Artivion, Inc. (AORT) - S-3/A

  • SEC Filings
  • 03/23/2016

Artivion, Inc. (AORT) - UPLOAD

  • SEC Filings
  • 03/21/2016

Artivion, Inc. (AORT) - DEL AM

  • SEC Filings
  • 03/16/2016

Artivion, Inc. (AORT) - CORRESP

  • SEC Filings
  • 03/15/2016

Artivion, Inc. (AORT) - S-3

  • SEC Filings
  • 03/09/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/09/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/04/2016

Artivion, Inc. (AORT) - 4/A

  • SEC Filings
  • 03/01/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/01/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/23/2016

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 02/23/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/19/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/16/2016

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/11/2016

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/09/2016

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/03/2016

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 01/28/2016

Artivion, Inc. (AORT) - D

  • SEC Filings
  • 01/28/2016

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/26/2016

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/30/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/01/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 10/23/2015

Artivion, Inc. (AORT) - 4/A

  • SEC Filings
  • 09/17/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/17/2015

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 09/17/2015

Artivion, Inc. (AORT) - 4/A

  • SEC Filings
  • 09/15/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/15/2015

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 09/15/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/14/2015

Artivion, Inc. (AORT) - CORRESP

  • SEC Filings
  • 09/02/2015

Artivion, Inc. (AORT) - S-3/A

  • SEC Filings
  • 08/21/2015

Artivion, Inc. (AORT) - S-3

  • SEC Filings
  • 08/05/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/04/2015

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/29/2015

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 04/27/2015

Artivion, Inc. (AORT) - ARS

  • SEC Filings
  • 04/24/2015

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/20/2015

Artivion, Inc. (AORT) - 4/A

  • SEC Filings
  • 04/15/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 04/13/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 04/02/2015

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 04/02/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/10/2015

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 02/27/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/27/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/25/2015

Artivion, Inc. (AORT) - 4/A

  • SEC Filings
  • 02/20/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/20/2015

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/13/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/13/2015

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/05/2015

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/15/2015

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/10/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/05/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/04/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/26/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/12/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/06/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/04/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/03/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/09/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/04/2014

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 09/04/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 09/03/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/26/2014

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 08/25/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/19/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/15/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/14/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/31/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/29/2014

Artivion, Inc. (AORT) - S-8

  • SEC Filings
  • 07/21/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/12/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/11/2014

Artivion, Inc. (AORT) - SD

  • SEC Filings
  • 05/29/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/19/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/14/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/06/2014

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/08/2014

Artivion, Inc. (AORT) - ARS

  • SEC Filings
  • 04/08/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/10/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/26/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/25/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/20/2014

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/14/2014

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/10/2014

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 01/31/2014

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/31/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/20/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/02/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/26/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/13/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/12/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/07/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/06/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/05/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 10/31/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/28/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/14/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/09/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/02/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/16/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/27/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/07/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/03/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/20/2013

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/03/2013

Artivion, Inc. (AORT) - ARS

  • SEC Filings
  • 04/03/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 03/11/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/26/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/19/2013

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/13/2013

Artivion, Inc. (AORT) - SC 13G

  • SEC Filings
  • 02/11/2013

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/01/2013

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/26/2012

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 12/14/2012

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 12/13/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/03/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/15/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/13/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/28/2012

Artivion, Inc. (AORT) - S-8

  • SEC Filings
  • 06/22/2012

Artivion, Inc. (AORT) - S-4

  • SEC Filings
  • 06/22/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/11/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 06/05/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/31/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/23/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 05/18/2012

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 05/18/2012

Artivion, Inc. (AORT) - DEFA14A

  • SEC Filings
  • 05/09/2012

Artivion, Inc. (AORT) - CORRESP

  • SEC Filings
  • 04/25/2012

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 04/23/2012

Artivion, Inc. (AORT) - DEF 14A

  • SEC Filings
  • 04/06/2012

Artivion, Inc. (AORT) - ARS

  • SEC Filings
  • 04/06/2012

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 04/02/2012

Artivion, Inc. (AORT) - UPLOAD

  • SEC Filings
  • 03/21/2012

Artivion, Inc. (AORT) - S-3

  • SEC Filings
  • 02/22/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/22/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/21/2012

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/14/2012

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/09/2012

Artivion, Inc. (AORT) - SC 13G/A

  • SEC Filings
  • 02/08/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/08/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 02/07/2012

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 02/06/2012

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 02/02/2012

Artivion, Inc. (AORT) - 3

  • SEC Filings
  • 01/09/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 01/04/2012

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/16/2011

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 12/07/2011

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/23/2011

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 11/21/2011

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 11/21/2011

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/23/2011

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/17/2011

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 08/11/2011

Artivion, Inc. (AORT) - 4

  • SEC Filings
  • 07/28/2011

Artivion, Inc. (AORT) - CT ORDER

  • SEC Filings
  • 07/22/2011
Press Releases
StockPrice Release
More Headlines
News

Artivion Reports First Quarter 2024 Financial Results

  • First Quarter Highlights: Achieved revenue of $97.4 million in the first quarter of 2024 versus $83.2 million in the first quarter of 2023, an increase of 17% on a GAAP basis and 16% on a non-GAAP constant currency basis Net income was $7.5 million or $0.18 per fully diluted share and non-GAAP net income was $2.6 million or $0.06 per fully diluted share in the first quarter of 2024 Non-GAAP adjusted EBITDA increased 60% to $17.3 million in the first quarter of 2024 compared to $10.8 million in the first quarter of 2023 Revised FY24 revenue guidance to 9% to 12% year-over-year growth on a constant currency basis, an increase of 0.5% at the midpoint ATLANTA , May 6, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the first quarter ended March 31, 2024. "We are very pleased with our first quarter results as we maintained growth momentum and executed on key operational priorities.
  • 05/06/2024

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

  • 5-Year Real-World Safety and Efficacy Data from On-X Aortic Heart Valve Low INR Post-Market Study Demonstrate Even Better Patient Outcomes Than Predicted by the PROACT IDE Study Late-Breaking 30-Day Data from AMDS PERSEVERE Trial Demonstrate Positive Aortic Remodeling Outcomes and Zero DANE Tears ATLANTA , April 29, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of new clinical data from the On-X Low INR post-market study and AMDS PERSEVERE Trial at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting in Toronto, Canada. Presentations highlighted 5-year real-world safety and efficacy data from the On-X Aortic Heart Valve Low INR post-market study that demonstrate even better patient outcomes than predicted by the On-X Aortic Heart Valve PROACT IDE Study, as well as Late-Breaking data from the AMDS PERSEVERE Trial demonstrating, at 30-days post-AMDS implantation, positive aortic remodeling outcomes and zero distal anastomotic new entry (DANE) tears.
  • 04/29/2024

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

  • ATLANTA , April 22, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024 financial results will be released on Monday, May 6, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m.
  • 04/22/2024

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

  • Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
  • 04/15/2024

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

  • ATLANTA, April 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming 23rd Annual Needham Virtual Healthcare Conference. The Company's virtual fireside chat is scheduled to begin at 10:15 a.m.
  • 04/01/2024

Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run?

  • Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
  • 03/29/2024

Are Medical Stocks Lagging Artivion (AORT) This Year?

  • Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
  • 03/28/2024

3 Buy-Rated Small Caps Flexing Big Growth

  • Small-cap stocks can be solid considerations for those who can handle a higher level of volatility. Analysts have recently become bullish on these three.
  • 03/19/2024

Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024

  • We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
  • 03/14/2024

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

  • Here is how Artivion (AORT) and Astria Therapeutics, Inc. (ATXS) have performed compared to their sector so far this year.
  • 03/12/2024

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

  • ATLANTA , March 6, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference. The Company's virtual fireside chat is scheduled to begin at 10:40 a.m.
  • 03/06/2024

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

  • Here is how Artivion (AORT) and Boston Scientific (BSX) have performed compared to their sector so far this year.
  • 02/22/2024

Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?

  • Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
  • 02/22/2024

Wall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a Bet

  • The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in Artivion (AORT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
  • 02/21/2024

Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript

  • Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript
  • 02/15/2024

Artivion (AORT) Surpasses Q4 Earnings and Revenue Estimates

  • Artivion (AORT) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to earnings of $0.10 per share a year ago.
  • 02/15/2024

Artivion Reports Fourth Quarter and Full Year 2023 Financial Results

  • Fourth Quarter and Recent Business Highlights: Achieved revenue of $93.7 million in the fourth quarter of 2023 versus $79.4 million in the fourth quarter of 2022, an increase of 18% on a GAAP basis and 15% on a non-GAAP constant currency basis Achieved revenue of $354.0 million for the full year of 2023 versus $313.8 million for the full year of 2022, an increase of 13% on a GAAP basis and 12% on a non-GAAP constant currency basis Net loss was ($4.0) million or ($0.10) per fully diluted share and non-GAAP net income was $4.6 million or $0.11 per fully diluted share in the fourth quarter of 2023 Non-GAAP adjusted EBITDA increased 40% to $15.3 million in the fourth quarter of 2023 compared to $11.0 million in the fourth quarter of 2022. For the full year adjusted EBITDA increased 29.5% to $53.8 million Generated $11.4 million of free cash flow for the full year of 2023 Closed non-dilutive credit agreement for $350.0 million of senior secured, interest-only, credit facilities with 6-year maturities Completed enrollment of the AMDS PERSEVERE clinical trial and presented positive results of the full IDE cohort at the STS Annual Meeting demonstrating a significant reduction of all-cause mortality and primary major adverse events (MAEs) at 30-days following AMDS implantation Appointed Lance A.
  • 02/15/2024

This suspicious congressional trade returned 48% in two months

  • Reports of various elected U.S. officials making significant, conveniently timed trades are not, unfortunately, rare. While much focus has been given to Nancy Pelosi and her husband – and indeed, their trading strategy has so far proven successful, as made evident by the returns of a trading bot that copies their investments – Senator Tina Smith has been increasingly in the news in the final months of 2023.
  • 12/27/2023

This trading bot buys stocks bought by US politicians; Here are its biggest holdings

  • In May 2022, Quiver Quantitative, an alternative data platform catering to retail investors, introduced a trading bot that mimics the stock purchases made by influential US politicians.
  • 12/22/2023

Senator up 30% on this year's two most suspicious trades

  • Largely thanks to the efforts of the online investor community, interesting, suspicious, and conveniently timed trades made by elected officials in the U.S. have come under increased scrutiny in recent years.
  • 12/13/2023

Artivion, Inc. (AORT) Q3 2023 Earnings Call Transcript

  • Artivion, Inc. (NYSE:AORT ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group Pat Mackin - Chairman, President, and Chief Executive Officer Ashley Lee - Executive Vice President and Chief Financial Officer Conference Call Participants John McAulay - Stifel Shaymus Contorno - Oppenheimer Joseph Stringer - Needham Frank Takkinen - Lake Street Capital Jeffrey Cohen - Ladenburg Thalmann Operator Welcome to the Artivion Third Quarter 2023 Financial Conference Call. At this time, all participants are in a listen-only mode.
  • 11/05/2023

Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025

  • Artivion has used M&A to reposition itself towards growth opportunities in aortic disease care and heart valves. The company's legacy operations contribute positively to revenue and margins but have limited growth prospects. The success of Artivion's stent-graft business and ongoing clinical trials will determine its future growth potential, as those trials are the gating factor to over $1.2B in potential revenue.
  • 10/13/2023

Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

  • ATLANTA , Sept. 14, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Gilmartin Group Emerging Growth Company Showcase on Thursday, September 21, 2023.
  • 09/14/2023

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

  • Here is how Artivion (AORT) and Augmedix, Inc. (AUGX) have performed compared to their sector so far this year.
  • 08/24/2023

Time to Buy These Medical Stocks as Earnings Approach

  • Quarterly results from large retailers will highlight this week's earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well.
  • 08/14/2023

Does Artivion (AORT) Have the Potential to Rally 52.78% as Wall Street Analysts Expect?

  • The average of price targets set by Wall Street analysts indicates a potential upside of 52.8% in Artivion (AORT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
  • 08/10/2023

Artivion, Inc. (AORT) Q2 2023 Earnings Call Transcript

  • Artivion, Inc. (NYSE:AORT ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 AM ET Company Participants Laine Morgan – Gilmartin Group Pat Mackin – Chief Executive Officer Ashley Lee – Chief Financial Officer Conference Call Participants John McAulay – Stifel Shaymus Contorno – Oppenheimer Frank Takkinen – Lake Street Capital Markets Operator Greetings, and welcome to the Artivion Second Quarter 2023 Financial Conference Call. At this time, all participants are in a listen-only mode.
  • 08/05/2023

Artivion (AORT) Q2 Earnings and Revenues Top Estimates

  • Artivion (AORT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.03 per share a year ago.
  • 08/03/2023

Artivion: On-X Sales Double 5-Year Average, Far More Constructive View (Rating Upgrade)

  • Artivion, Inc. has begun to recover from the fallout after its PROACT trial failure. On-X sales almost doubled the 5-year average range in Q1, and management look to 15% CAGR in sales moving forward. Net-net, revise to buy, eyeing $24 initial objective.
  • 07/19/2023

Artivion, Inc. (AORT) Q1 2023 Earnings Call Transcript

  • Artivion, Inc. (NYSE:AORT ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Brian Johnston - Vice President, Gilmartin Group Pat Mackin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Jeffrey Cohen - Ladenburg Thalmann Frank Takkinen - Lake Street Capital Operator Good day, ladies and gentlemen. And welcome to the Artivion First Quarter 2023 Financial Conference Call.
  • 05/07/2023

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2023 Financial Results

  • ATLANTA , April 20, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2023 financial results will be released on Thursday, May 4, 2023 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m.
  • 04/20/2023

Artivion: Reaffirm Hold As Pressures To Growth Remain

  • Artivion: Reaffirm Hold As Pressures To Growth Remain.
  • 04/20/2023

Why Artivion Stock Popped on Friday

  • There's nothing like an upside earnings surprise to juice the price of a company's shares.
  • 02/17/2023

Artivion, Inc. (AORT) Q4 2022 Earnings Call Transcript

  • Artivion, Inc. (NYSE:AORT ) Q4 2022 Earnings Conference Call February 16, 2023 4:30 PM ET Company Participants Brian Johnston - Vice President at Gilmartin Group Pat Mackin - Chairman, President & CEO Ashley Lee - EVP & CFO Conference Call Participants Charlie Montang - Lake Street Jeffrey Cowen - Latin Bert, Dolman Rick Wise - Stifel Michael Matson - Needham and Company Suraj Kalia - Oppenheimer Operator Greetings and welcome to Artivion's Fourth Quarter and Full Year End 2022 Financial Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Brian Johnston, Vice President at Gilmartin Group.
  • 02/16/2023

Artivion (AORT) Q4 Earnings Surpass Estimates

  • Artivion (AORT) delivered earnings and revenue surprises of 158.82% and 1.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 02/16/2023

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results

  • ATLANTA , Feb. 2, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2022 financial results will be released on Thursday, February 16, 2023 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m.
  • 02/02/2023

Artivion (AORT) Upgraded to Buy: What Does It Mean for the Stock?

  • Artivion (AORT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
  • 11/25/2022

Artivion, Inc. (AORT) Q3 2022 Earnings Call Transcript

  • Artivion, Inc. (NYSE:AORT ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Sam Bentzinger - Gilmartin Group Pat Mackin - Chairman, President & CEO Ashley Lee - EVP & CFO Conference Call Participants John McAulay - Stifel Frank Takkinen - Lake Street Capital Suraj Kalia - Oppenheimer & Co. Operator Good day, ladies and gentlemen, and welcome to the Artivion 3Q 2022 Financial Conference Call. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host, Sam Bentzinger from the Gilmartin Group.
  • 11/05/2022

Artivion (AORT) Reports Q3 Loss, Tops Revenue Estimates

  • Artivion (AORT) delivered earnings and revenue surprises of 54.55% and 0.31%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 11/03/2022

Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver

  • Artivion, Inc.'s decision to pull the PROACT Xa trial resulted in heavy downside for the share price. Investors have sold positions rapidly such that the stock trades at multi-year lows.
  • 09/27/2022

Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference

  • ATLANTA , Sept. 14, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at the upcoming Deutsche Bank 30th Annual Leveraged Finance Conference on Wednesday, September 21, 2022.
  • 09/14/2022

Artivion to Participate in Upcoming Investor Conferences

  • ATLANTA , Sept. 6, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.
  • 09/06/2022

Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

  • ATLANTA , Aug. 24, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present virtually at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase on Wednesday, August 31, 2022.  The Company's presentation is scheduled to begin at 1:30 p.m.
  • 08/24/2022

Artivion, Inc. (AORT) CEO James Mackin on Q2 2022 Results - Earnings Call Transcript

  • Artivion, Inc. (NYSE:AORT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Brian Johnston - Gilmartin Group James Mackin - Chairman, President & CEO David Lee - EVP, COO & CFO Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company Suraj Kalia - Oppenheimer Operator Greetings, and welcome to the Artivion Second Quarter 2022 Financial Results Conference Call. [Operator Instructions].
  • 08/07/2022

Artivion (AORT) Soars 10.2%: Is Further Upside Left in the Stock?

  • Artivion (AORT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
  • 06/23/2022

Artivion, Inc. (AORT) CEO Pat Mackin on Q1 2022 Results - Earnings Call Transcript

  • Artivion, Inc. (NYSE:AORT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Brian Johnston - Investor Relations Pat Mackin - Chief Executive Officer Ashley Lee - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Suraj Kalia - Oppenheimer Operator Greetings and welcome to the Artivion First Quarter 2022 Financial Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
  • 05/08/2022

Artivion, Inc. (AORT) CEO J. Patrick Mackin on Q4 2021 Results - Earnings Call Transcript

  • Artivion, Inc. (AORT) CEO J. Patrick Mackin on Q4 2021 Results - Earnings Call Transcript
  • 02/17/2022

Artivion (AORT) Reports Break-Even Earnings for Q4

  • Artivion (AORT) delivered earnings and revenue surprises of 100% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 02/17/2022
Unlock
AORT Ratings Summary
AORT Quant Ranking